Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 12
Tables & Figures: 161
Countries covered: 19
Pages: 130
Download Free PDF

Enteric Disease Testing Market
Get a free sample of this reportGet a free sample of this report Enteric Disease Testing Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Enteric Disease Testing Market Size
The global enteric disease testing market size was valued at USD 2.2 billion in 2024. The market is expected to reach from USD 2.3 billion in 2025 to USD 3.3 billion in 2034, growing at a CAGR of 4.2% during the forecast period. The high market growth is attributed to the increasing incidence of enteric infections globally, rising awareness and surveillance initiatives, technological advancements in diagnostic testing, and surging demand for point-of-care testing (POCT), among other contributing factors.
The growing incidence of enteric diseases such as cholera, salmonellosis, rotavirus, and amoebiasis is increasing market growth. As per the World Health Organization (WHO) 29 countries reported cholera cases in 2022 with a staggering figure of 472,697 cases and 2,348 deaths globally. These infections are mainly seen in low- and middle-income countries because of the lack of proper sanitation facilities and contaminated water supplies. There is ongoing need for timely and reliable diagnostics as these infections are characterized by recurrent outbreaks along with endemic persistence. Early detection through appropriate testing facilitates effective interventions, leading to improved patient outcomes and better control efforts beyond mere avoidance.
Moreover, the rising popularity of capsule endoscopy, ingestible sensors, as well as drug delivery systems have emphasized the need for functional testing of enteric devices pertaining to dissolution, transit time considerations, as well as localized release within gastrointestinal structures. As developers pursue accuracy validation for inventive mechanisms, the emphasis on precision reinforces market growth vis-a-vis this trend.
Enteric disease testing refers to the diagnostic processes used to detect infections that affect the gastrointestinal tract, typically caused by bacteria, viruses, or parasites. These tests focus on identifying infectious agents for conditions such as diarrhea, typhoid, cholera and dysentery. Common testing methods include stool culture, antigen detection, molecular assays and multiplex PCR panels. The aim is to facilitate prompt diagnosis and treatment, during outbreaks and in high burden areas.
Enteric Disease Testing Market Trends
The market is witnessing significant growth, driven by the shift toward molecular and multiplex testing technologies, the rise of point-of-care and rapid diagnostic tests (RDTs), increasing adoption of syndromic testing panels, surging need for AI and automation in diagnostics, and growing emphasis on One health and global surveillance, among other factors.
Enteric Disease Testing Market Analysis
Based on disease, the market is segmented into bacterial enteric disease, viral enteric disease, and parasitic enteric disease. The bacterial enteric disease segment has asserted its dominance in the market by securing a significant market share of 55.1% in 2024 and is anticipated to grow at a CAGR of 4.6% over the forecast years.
Based on test type, the enteric disease testing market is classified into immunoassay, molecular, conventional, chromatography & spectrometry, and other test types. The immunoassay segment accounted for the highest market revenue of USD 790.6 million in 2024 and is poised to grow at a CAGR of 4.3%.
Based on end use, the enteric disease testing market is categorized into hospitals, diagnostic laboratories, research & academic institutes, and other end users. The hospitals segment dominated the market in 2024 and accounted for USD 998.3 million and is anticipated to grow at a CAGR of 4.4% during the forecast period.
U.S. enteric disease testing market was valued at USD 755 million and USD 776 million in 2021 and 2022, respectively. The market size reached USD 822.4 million in 2024, growing from USD 798.6 million in 2023.
Europe enteric disease testing market accounted for USD 606 million in 2024 and is anticipated to show lucrative growth over the forecast period.
UK enteric disease testing market in the Europe is projected to grow remarkably in the coming years.
The Asia Pacific enteric disease testing market is anticipated to grow at the highest CAGR of 5.2% during the analysis timeframe.
China holds a dominant position in the Asia Pacific enteric disease testing market.
The Brazil enteric disease testing market is experiencing robust growth in Latin America market.
Saudi Arabia enteric disease testing market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
Enteric Disease Testing Market Share
The global market is moderately consolidated, with prominent pharmaceutical and diagnostics companies leading space, while innovation continues to thrive among emerging players and specialized firms. Major market participants such as Abbott Laboratories, bioMérieux, Danaher and Becton, Dickinson and Company holds around 20-25% market share in the global market, These players are actively pursuing strategic initiatives to enhance their market presence and address the growing demand for accurate and rapid enteric disease diagnostics. These industry leaders are leveraging product innovation, strategic partnerships, acquisitions, and geographic expansion to stay competitive and meet evolving clinical needs.
Enteric Disease Testing Market Companies
Prominent players operating in the enteric disease testing industry include:
Enteric Disease Testing Industry News:
The enteric disease testing market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:
Market, By Disease
Market, By Test Type
Market, By End Use
The above information is provided for the following regions and countries: